These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 27612194

  • 21. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE.
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
    [Abstract] [Full Text] [Related]

  • 22. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF.
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [Abstract] [Full Text] [Related]

  • 23. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
    Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ.
    J Neurosci; 2008 Sep 24; 28(39):9850-6. PubMed ID: 18815269
    [Abstract] [Full Text] [Related]

  • 24. A six-year longitudinal PET study of (+)-[11C]DTBZ binding to the VMAT2 in monkey brain.
    Kilbourn MR, Koeppe RA.
    Nucl Med Biol; 2017 Dec 24; 55():34-37. PubMed ID: 29031997
    [Abstract] [Full Text] [Related]

  • 25. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M.
    Nucl Med Biol; 2008 Nov 24; 35(8):825-37. PubMed ID: 19026944
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reference tissue models in the assessment of 11 C-DTBZ binding to the VMAT2 in rat striatum: A test-retest reproducibility study.
    Avendaño-Estrada A, Ávila-Rodríguez MA.
    Synapse; 2018 Jun 24; 72(6):e22029. PubMed ID: 29381820
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers.
    Kilbourn MR.
    Nucl Med Biol; 2010 Nov 24; 37(8):869-71. PubMed ID: 21055616
    [Abstract] [Full Text] [Related]

  • 35. Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter.
    DaSilva JN, Kilbourn MR, Mangner TJ.
    Appl Radiat Isot; 1993 Dec 24; 44(12):1487-9. PubMed ID: 7903060
    [Abstract] [Full Text] [Related]

  • 36. Molar activity of [18F]FP-(+)-DTBZ radiopharmaceutical: Determination and its effect on quantitative analysis of VMAT2 autoradiography.
    Liu C, Tang J, Xu Y, Cao S, Fang Y, Zhao C, Chen Z.
    J Pharm Biomed Anal; 2021 Sep 05; 203():114212. PubMed ID: 34153939
    [Abstract] [Full Text] [Related]

  • 37. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
    Chan GL, Holden JE, Stoessl AJ, Samii A, Doudet DJ, Dobko T, Morrison KS, Adam M, Schulzer M, Calne DB, Ruth TJ.
    J Nucl Med; 1999 Feb 05; 40(2):283-9. PubMed ID: 10025836
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.